GOLDEN THROAT HOLDINGS GROUP COMPANY LIMITED

Golden Throat Holdings Group Company Limited

6896

KYG3961J1022

Pharmaceuticals

Delayed Hong Kong S.E. Other stock markets 03:08:37 2024-05-17 EDT			5-day change	1st Jan Change
3.8 ^HKD	+0.26%		-1.04%	+13.43%

05-01	Golden Throat’s Profit Declines 11% in 2023	MT
03-27	Golden Throat Holdings Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Golden Throat Holdings Group Company Limited Announces Resignation of Lu Xinghong as Executive Director

March 25, 2022 at 07:57 am

Golden Throat Holdings Group Company Limited announced that Mr. LU Xinghong, executive director of the Company, has resigned as exectuve director and deputy general manager of the Company as he has reached the age for retirement with effect from 25 March 2022.

Latest news about Golden Throat Holdings Group Company Limited

Golden Throat’s Profit Declines 11% in 2023	05-01	MT
Golden Throat Holdings Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-27	CI
Golden Throat Holdings Group Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Golden Throat’s Profit to See 110% Boost in H1	23-08-15	MT
Golden Throat Holdings Group Company Limited Provides Group Earnings Guidance for the Six Months Ended 30 June 2023	23-08-14	CI
Golden Throat Holdings Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-29	CI
Golden Throat Forecasts 50% Rise in 2022 Profit; Shares Climb 7%	23-03-10	MT
Golden Throat Holdings Group Company Limited Provides Earnings Guidance for the Year Ended 31 December 2022	23-03-09	CI
Golden Throat Holdings Group's H1 Net Profit Falls 30.4%	22-08-25	MT
Golden Throat Holdings Group Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-24	CI
Golden Throat Warns of 30% Profit Drop in H1	22-08-05	MT
Golden Throat Holdings Group Company Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2022	22-08-05	CI
Golden Throat Holdings Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Golden Throat Holdings Group Company Limited Announces Resignation of Lu Xinghong as Executive Director	22-03-25	CI
Golden Throat Holdings Group Company Limited Provides Earnings Guidance for the Fiscal Year Ended December 31, 2021	22-03-16	CI
Golden Throat Holdings Group Company Limited Announces Management Changes	22-03-09	CI
Hong Kong Stocks Rebound from 14-Month Low; Golden Throat Tanks 38%	21-12-01	MT
Golden Throat Shareholders Reject $68 Million Go-Private Offer; Shares Tank 34%	21-12-01	MT
Golden Throat Shareholders to Vote Nov. 30 on $68 Million Go-Private Deal	21-10-28	MT
Golden Throat Holdings Group Company Limited Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-26	CI
Golden Throat : Appoints Financial Adviser for Affirma Capital's Go-Private Bid	21-08-23	MT
Golden Throat : Receives $68 Million Go-Private Bid from Singaporean Private Equity Firm	21-08-13	MT
Golden Throat Holdings Group Company Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2021	21-08-10	CI
Golden Throat Holdings Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2020	21-03-30	CI
Golden Throat Holdings Group Company Limited Announces Change of Principal Place of Business in Hong Kong	21-03-30	CI

Chart Golden Throat Holdings Group Company Limited

Duration

Period

Chart Golden Throat Holdings Group Company Limited

More charts

Company Profile

Golden Throat Holdings Group Company Limited is principally engaged in the manufacture and sales of pharmaceutical, healthcare food and other products. The Companyâs flagship product is Golden Throat Lozenges (OTC), which is a type of lozenge mainly designed to relieve symptoms of sore, dry throat and hoarse voice caused by acute pharyngitis. The Company's subsidiaries include Golden Throat Industrial Holdings Limited, Guangxi Golden Throat Investment Consulting Co., Ltd. and Guangxi Golden Throat Co., Ltd..

Sector

Pharmaceuticals

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
GOLDEN THROAT HOLDINGS GROUP COMPANY LIMITED	+13.43%	359M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+21.48%	44.15B
OTSUKA HOLDINGS CO., LTD.	+23.03%	23.02B
SANDOZ GROUP AG	+20.73%	15.33B
CIPLA LIMITED	+12.34%	13.74B
ZYDUS LIFESCIENCES LIMITED	+49.91%	12.16B
ONO PHARMACEUTICAL CO., LTD.	-10.02%	6.84B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+13.88%	5.66B

Generic Pharmaceuticals